[go: up one dir, main page]

NL8603132A - Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen. - Google Patents

Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen. Download PDF

Info

Publication number
NL8603132A
NL8603132A NL8603132A NL8603132A NL8603132A NL 8603132 A NL8603132 A NL 8603132A NL 8603132 A NL8603132 A NL 8603132A NL 8603132 A NL8603132 A NL 8603132A NL 8603132 A NL8603132 A NL 8603132A
Authority
NL
Netherlands
Prior art keywords
antibody
iats
pseudomonas aeruginosa
serotypes
fisher
Prior art date
Application number
NL8603132A
Other languages
English (en)
Dutch (nl)
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NL8603132A publication Critical patent/NL8603132A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8603132A 1985-12-10 1986-12-09 Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen. NL8603132A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80739485A 1985-12-10 1985-12-10
US80739485 1985-12-10
US93117986A 1986-11-24 1986-11-24
US93117986 1986-11-24

Publications (1)

Publication Number Publication Date
NL8603132A true NL8603132A (nl) 1987-07-01

Family

ID=27123006

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8603132A NL8603132A (nl) 1985-12-10 1986-12-09 Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen.

Country Status (21)

Country Link
US (4) US5378812A (fr)
JP (1) JPH07116237B2 (fr)
KR (1) KR910008361B1 (fr)
CN (1) CN86108380A (fr)
AT (1) AT400441B (fr)
BE (1) BE905890A (fr)
CH (1) CH677362A5 (fr)
DE (1) DE3642095C2 (fr)
DK (1) DK594586A (fr)
FI (1) FI86377C (fr)
FR (1) FR2593826B1 (fr)
GB (1) GB2185266B (fr)
HU (1) HUT41836A (fr)
IE (1) IE59741B1 (fr)
IT (1) IT1199735B (fr)
LU (1) LU86711A1 (fr)
NL (1) NL8603132A (fr)
NO (1) NO178718C (fr)
NZ (1) NZ218499A (fr)
PT (1) PT83894B (fr)
SE (1) SE468831B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (fr) * 1986-08-06 1989-02-15 Merck & Co. Inc. Anticorps humains thérapeutiques anti-pseudomonas aeruginosa
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
DE3786173T2 (de) * 1986-12-15 1993-12-16 Mitsui Toatsu Chemicals Menschlicher monoklonaler antikörper und arzneimittel zur prophylaxe und behandlung von infektiösen krankheiten.
WO1990011350A1 (fr) * 1989-03-20 1990-10-04 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain reagissant avec le pseudomonas aeruginosa, cellule produisant cet anticorps, procede de production et preparation pharmaceutique
JPH01197500A (ja) * 1988-01-29 1989-08-09 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
CA1341375C (fr) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions pour le traitement et la prevention d'infections dues a des bacteries gram negatif, ainsi que leurs methodes d'utilisation
EP0382031A3 (fr) * 1989-02-10 1991-06-26 Miles Inc. Anticorps monoclonaux dans une préparation de globuline d'immunsérum
US4994269A (en) * 1989-03-17 1991-02-19 Miles Inc. Topical use of antibodies for prevention or treatment of pseudomonas infections
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
JPH0329196A (ja) * 1989-05-09 1991-02-07 Advanced Micro Devicds Inc センス増幅器
US5858728A (en) * 1991-03-13 1999-01-12 Common Services Agency Monoclonal antibody against LPS core
US20030096315A1 (en) 2000-05-03 2003-05-22 Sanders Mitchell C. Device for detecting bacterial contamination and method of use
WO2003063693A2 (fr) * 2002-01-31 2003-08-07 Expressive Constructs, Inc. Methode de detection de micro-organismes
EP1506217A4 (fr) * 2002-05-29 2006-04-12 Jackson H M Found Military Med Methodes d'identification de biomarqueurs genomiques et proteomiques pour la mucoviscidose, jeux ordonnes d'echantillons comprenant ces biomarqueurs et methodes d'utilisation de ces jeux ordonnes d'echantillons
JP5271475B2 (ja) 2002-11-26 2013-08-21 ザ ユニヴァーシティー オヴ シカゴ 微生物媒介上皮疾患の予防及び治療のための材料並びに方法
US20060257955A1 (en) * 2003-01-31 2006-11-16 Colpas Gerard J Method for detecting escherichia coli
DE602004011105T2 (de) 2003-11-03 2008-12-18 Ethicon, Inc. Verfahren, peptide und biosensoren mit eignung zum nachweis eines breiten spektrums von bakterien
EP1690875A1 (fr) * 2005-02-14 2006-08-16 Kenta Biotech AG Anticorps monoclonal humain specifique pour lipoplysaccharides (LPS) de la Pseudomonas aeruginosa serotype IATS O11
AU2007245258B2 (en) * 2006-05-01 2013-09-19 Bioness Neuromodulation Ltd. Improved functional electrical stimulation systems
EP2393515A1 (fr) * 2009-02-04 2011-12-14 Kalobios Pharmaceuticals, Inc. Antibiotique en combinaison et thérapie antibiotique pour traiter une infection par pseudomonas aeruginosa
CN102858977A (zh) * 2010-02-18 2013-01-02 明治制果药业株式会社 铜绿假单胞菌g血清型脂多糖抗体
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
JPS59137497A (ja) * 1983-01-20 1984-08-07 ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア 抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58216125A (ja) * 1982-06-09 1983-12-15 Asahi Chem Ind Co Ltd ヒト抗体の産生方法
JPS5929622A (ja) * 1982-08-10 1984-02-16 Meiji Seika Kaisha Ltd モノクロ−ナル抗体、その製造法およびその用途
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US4587121A (en) * 1983-06-14 1986-05-06 Miles Laboratories, Inc. High titer Pseudomonas immune serum globulin
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
WO1985002685A1 (fr) * 1983-12-12 1985-06-20 Meru, Inc. Procede et substances permettant l'identification de micro-organismes produisant du lipopolysaccharide
US4683196A (en) * 1983-12-12 1987-07-28 Meru, Inc. Method and materials for the identification of lipopolysaccharide producing microorganisms
JPS60248625A (ja) * 1984-05-25 1985-12-09 Mitsui Toatsu Chem Inc 抗緑膿菌モノクロ−ナル抗体、その製法ならびに用途
JP2565303B2 (ja) * 1984-05-25 1996-12-18 三井東圧化学株式会社 緑膿菌感染症の予防治療剤
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
DE3426903A1 (de) * 1984-07-20 1986-01-23 Biotest Pharma GmbH, 6000 Frankfurt Eine immunglobulinpraeparation in kombination mit einer anderen pharmakologisch wirksamen praeparation zur verwendung bei der behandlung von krankheiten
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS6229175A (ja) * 1985-07-29 1987-02-07 Nippon Telegr & Teleph Corp <Ntt> 電界効果型トランジスタの製造方法
EP0211352B1 (fr) * 1985-08-01 1994-03-16 Miles Inc. Anticorps protecteurs contre des déterminants sérotypiques d'antigènes flagellaires
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus
AU615162B2 (en) * 1986-07-03 1991-09-26 Genetic Systems Corporation Monoclonal antibodies to pseudomonas aeruginosa flagella
EP0256713A3 (fr) * 1986-08-06 1989-02-15 Merck & Co. Inc. Anticorps humains thérapeutiques anti-pseudomonas aeruginosa

Also Published As

Publication number Publication date
HUT41836A (en) 1987-05-28
FI865027A0 (fi) 1986-12-10
ATA328286A (de) 1995-05-15
NO178718C (no) 1996-05-22
US5627067A (en) 1997-05-06
NO864971D0 (no) 1986-12-10
DK594586D0 (da) 1986-12-10
DE3642095C2 (de) 1998-10-01
CH677362A5 (fr) 1991-05-15
US5378812A (en) 1995-01-03
KR870005648A (ko) 1987-07-06
FI86377B (fi) 1992-05-15
US5628996A (en) 1997-05-13
NZ218499A (en) 1990-04-26
FR2593826B1 (fr) 1990-11-16
PT83894A (en) 1987-01-01
FR2593826A1 (fr) 1987-08-07
IE863230L (en) 1987-06-10
JPH07116237B2 (ja) 1995-12-13
IT1199735B (it) 1988-12-30
AT400441B (de) 1995-12-27
PT83894B (pt) 1989-07-31
DK594586A (da) 1987-06-11
CN86108380A (zh) 1987-10-28
IE59741B1 (en) 1994-03-23
FI86377C (fi) 1992-08-25
KR910008361B1 (ko) 1991-10-12
LU86711A1 (fr) 1988-07-14
SE8605295D0 (sv) 1986-12-10
SE468831B (sv) 1993-03-29
GB2185266B (en) 1990-09-05
JPS62187417A (ja) 1987-08-15
FI865027A (fi) 1987-06-11
US5662905A (en) 1997-09-02
NO178718B (no) 1996-02-12
DE3642095A1 (de) 1987-07-02
NO864971L (no) 1987-06-11
GB8629540D0 (en) 1987-01-21
SE8605295L (sv) 1987-06-11
GB2185266A (en) 1987-07-15
IT8622630A0 (it) 1986-12-10
BE905890A (fr) 1987-06-10

Similar Documents

Publication Publication Date Title
NL8603132A (nl) Monoklonale antilichamen kruis-reactief en kruis-beschermend tegen p. aeruginosa serotypen.
US4689299A (en) Human monoclonal antibodies against bacterial toxins
EP0105804B1 (fr) Anticorps monoclonaux humains contre des toxines bactériennes
FI111336B (fi) Menetelmä Staphylococcus epidermidis tyyppi I:n polysakkaridiantigeenin sisältävän rokotteen ja antigeeninvastaisen hyperimmunoglobuliinin valmistamiseksi
JPH02283294A (ja) ヒトモノクローナル抗体
US4834976A (en) Monoclonal antibodies to pseudomonas aeruginosa flagella
JP2645343B2 (ja) 交差防御性ヒト単クローン性抗体またはその結合フラグメントを含む医薬組成物
NL194961C (nl) Compositie omvattende een component die in staat is tot reactie met Pseudomonas aeruginosa flagella, farmaceutisch preparaat, cellijn, monoklonaal antilichaam, werkwijze ter bepaling van Pseudomonas aeruginosa, alsmede pakket voor het detecteren daarvan.
JPS63500035A (ja) プソイドモナス　アエルギノサ　外毒素ａに対する保護用ヒトモノクロ−ナル抗体
JP2587770B2 (ja) 形質転換細胞

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BN A decision not to publish the application has become irrevocable